- Home
- AIRS vs TSVT Comparison
AIRS vs TSVT Comparison
Compare AIRS & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRS
- TSVT
- Stock Information
- Founded
- AIRS 2012
- TSVT 2021
- Country
- AIRS United States
- TSVT United States
- Employees
- AIRS N/A
- TSVT N/A
- Industry
- AIRS Medical/Nursing Services
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- AIRS Health Care
- TSVT Health Care
- Exchange
- AIRS Nasdaq
- TSVT Nasdaq
- Market Cap
- AIRS 400.5M
- TSVT 160.4M
- IPO Year
- AIRS 2021
- TSVT N/A
- Fundamental
- Price
- AIRS $5.35
- TSVT $3.07
- Analyst Decision
- AIRS Hold
- TSVT Buy
- Analyst Count
- AIRS 2
- TSVT 6
- Target Price
- AIRS $5.00
- TSVT $10.40
- AVG Volume (30 Days)
- AIRS 248.7K
- TSVT 297.4K
- Earning Date
- AIRS 11-08-2024
- TSVT 11-12-2024
- Dividend Yield
- AIRS N/A
- TSVT N/A
- EPS Growth
- AIRS N/A
- TSVT N/A
- EPS
- AIRS N/A
- TSVT N/A
- Revenue
- AIRS $188,780,000.00
- TSVT $45,620,000.00
- Revenue This Year
- AIRS N/A
- TSVT N/A
- Revenue Next Year
- AIRS $10.31
- TSVT $36.09
- P/E Ratio
- AIRS N/A
- TSVT N/A
- Revenue Growth
- AIRS N/A
- TSVT N/A
- 52 Week Low
- AIRS $2.92
- TSVT $2.78
- 52 Week High
- AIRS $9.20
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- AIRS 38.88
- TSVT 32.27
- Support Level
- AIRS $5.58
- TSVT $2.78
- Resistance Level
- AIRS $6.60
- TSVT $4.07
- Average True Range (ATR)
- AIRS 0.58
- TSVT 0.24
- MACD
- AIRS -0.15
- TSVT -0.05
- Stochastic Oscillator
- AIRS 0.43
- TSVT 12.02
About AIRS AirSculpt Technologies Inc.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.